Clinical Trials Logo

Clinical Trial Summary

Aspirin has been shown to reduce cardiovascular events in at risk individuals. Elucidation of mechanisms of aspirin resistance and a possible loss of effect of aspirin over time with chronic aspirin treatment necessitate a more precise method of measuring the "release phase" of platelet activation, including the release of dense granules from platelets.


Clinical Trial Description

This is a proposal for a pilot study to evaluate the feasibility of measuring 5-hydroxytryptamine (5-HT) release from platelets as an indicator of dense granule release during platelet activation in volunteers taking aspirin.

One phase of platelet response to activating agonists involves release of dense granules, which are known to contain 5HT (serotonin) and ATP. There are various methods of measuring the degranulation of platelets: ATP release can be measured using a lumiaggregometer, and release of 14C radiolabeled 5-HT from platelets. Using the aggregometer and a 14C labeled 5-HT assay can be used to measure 5-HT release from platelets.

Our experience suggests that ADP-induced ATP release is insensitive to detect very low levels of platelet dense granule release, which occurs in aspirin-treated subjects. The pilot study will permit optimizing the method for reliably detecting low levels of 5HT release in patients who achieve submaximal inhibition of the cyclooxygenase during aspirin treatment. ;


Study Design

Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT00942617
Study type Interventional
Source Vanderbilt University
Contact
Status Withdrawn
Phase N/A
Start date July 2009
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT04492423 - VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT02958657 - Effect of Exercise on Platelet Reactivity After Myocardial Infarction N/A
Completed NCT01815008 - Pharmacogenomics of Antiplatelet Response - I Phase 4
Completed NCT03039205 - Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor Phase 2
Completed NCT01557335 - A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540 Phase 1
Completed NCT05581238 - Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
Completed NCT00233428 - Study to Determine Racial and Gender Differences in Platelet Aggregation Phase 1
Completed NCT02112539 - Aggreguide A-100 ADP Assay Evaluation N/A
Completed NCT00923988 - Effect of Passive Smoking on Platelet Function and Endothelial Function N/A
Terminated NCT00748371 - Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration Phase 4
Recruiting NCT05702463 - Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II Phase 1
Recruiting NCT04842760 - PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
Recruiting NCT06236243 - Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults N/A
Completed NCT00763997 - Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages N/A
Active, not recruiting NCT03615846 - Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
Completed NCT04369534 - Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction Phase 4
Completed NCT01603966 - Low Dose Aspirin Studied With the AggreGuide N/A
Completed NCT01152229 - Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine N/A
Recruiting NCT03528603 - Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal N/A